Mycobacterium avium subsp. Paratuberculosis as a trigger of type-1 diabetes: Destination Sardinia, or beyond?

Gut Pathogens

Volumn 2, Issue 1, 2010, Pages

  Rani, Pittu ^a   Sechi, Leonardo ^b   Ahmed, Niyaz ^a  

^a UNIVERSITY OF HYDERABAD   (India)

^b UNIVERSITY OF SASSARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85006627555     PISSN: None     EISSN: 17574749     Source Type: Journal    
DOI: 10.1186/1757-4749-2-1     Document Type: Review

References (54)

1. Environmental risk factors in human type1 diabetes: an epidemiological perspective. Dahlquist G, Diabetes Metab Rev 1995 11 37 46 10.1002/dmr. 5610110104 7600906
2. Environmental factors in the etiology of type1 diabetes. Akerblom HK Vaarala O Hyoty H Ilonen J, Knip M, Am J Med Genet 2002 115 18 29 10.1002/ajmg.10340 12116173
3. Global and societal implication of the diabetes epidemic. Zimmet P Alberti KG Shaw J, Nature 2001 414 782 787 10.1038/414782a 11742409
4. Worldwide increase in incidence of type 1 diabetes- the analysis of the data on published incidence trends. Onkamo P Vaananen S, Karvonen M Tuomilehto J, Diabetologia 1999 42 1395 1403 10.1007/s001250051309 10651256
5. Biomarkers of susceptibility to type-1 diabetes with special reference to the Indian population. Mehra NK Kumar N Kaur G Kanga U, Tandon N, Indian J Med Res 2007 321 344 17496359
6. Susceptibility gene discovery for common metabolic and endocrine traits. McCarthy MI, J Mol Endocrinol 2002 28 1 17 10.1677/jme.0.0280001 11854095
7. Heterogeneity of type 1 diabetes: analysis of monozygotic twins in Great Britain and the United States. Redondo MJ Yu L Hawa M Mackenzie T, Pyke DA Eisenbarth GS, Leslie RDG, Diabetologia 2001 44 354 362 10.1007/s001250051626 11317668
8. Genetic liability of type1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow-up study. Hyttinen V Kaprio J Kinnunen L Koskenvuo M, Tuomilehto J, Diabetes 2003 52 1052 1055 10.2337/diabetes.52.4. 1052 12663480
9. Do microbes have a causal role in type1 diabetes? Lammi N Karvonen M Tuomilehto J, Med Sci Monit 2005 11 63 69
10. Increased numbers of in vivo activated T-cells in patients with recent onset insulin-dependent diabetes mellitus. Petersen LD Duinkerken G, Bruining GJ van Lier RA, deVries RR Roep BO, Journal of Autoimmunity 1996 9 731 737 10.1006/jaut.1996.0095 9115575
11. Activated CD4+ and CD8+ T-lymphocytes in newly diagnosed type 1 diabetes: a prospective study. Buschard K Damsbo P Ropke C, Diabetic Medicine 1990 7 132 136 10.1111/j.1464-5491.1990.tb01347.x 2137753
12. Mycobacterium avium subsp. paratuberculosis and its potential survival tactics. Rowe MT Grant IR, Lett Appl Microbiol 2006 42 305 311 10.1111/j.1472-765X.2006.01873.x 16599979
13. Mycobacterium avium subsp. Paratuberculosis in veterinary medicne. Harris NB Barletta RG, Clin Microbiol 2001 14 489 512 10.1128/CMR.14.3.489-512.2001
14. Amplified fragment length polymorphism reveals genomic variability among Mycobacterium avium subsp. paratuberculosis isolates. O'Shea B Khare S Bliss K Klein P, Ficht TA Adams LC, Rice-Ficht AC, Journal of clinical microbiology 2004 42 3600 3606 10.1128/JCM.42.8.3600-3606.2004 15297504
15. The potential role of wild rabbits Oryctolagus cuniculus in the epidemiology of paratuberculosis in domestic ruminants. Daniels MJ Henderson D, Greig A Stevenson K, Sharp JM Hutchings MR, Epidemiol Infect 2003 130 553 559 12825741
16. Possible transmission of Mycobacterium avium subspecies paratuberculosis through potable water: lesson from an urban cluster of Crohn's disease. Pierce E, Gut Pathog 2009 1 17 10.1186/1757-4749-1-17 19772668
17. Humoral immune responses of Type-1 Diabetes patients to Mycobacterium avium subspecies paratuberculosis lend support to the infectious trigger hypothesis. Sechi LA Rosu V, Pacifico A Fadda G, Ahmed N Zanetti S, Clin Vaccine Immunol 2008 15 320 326 10.1128/CVI.00381-07 18077612
18. Detection of viable Mycobacterium avium subsp. paratuberculosis in retail pasteurized whole milk by two culture methods and PCR. Ellingson JLE Anderson JL Koziczkowski JJ Radcliff RP, Sloan SJ Allen SE, Sullivan NM, J Food Prot 2005 68 966 972 15895728
19. Cow's milk exposure and type I diabetes mellitus. A critical overview of the clinical literature. Gerstein HC, Diabetes Care 1994 17 13 19 10.2337/diacare.17.1.13 8112184
20. IDDM and milk consumption. A case-control study in Sao Paulo, Brazil. Gimeno SG de Souza JM, Diabetes Care 1997 20 1256 1260 10.2337/diacare.20.8.1256 9250450
21. Paratuberculosis and Type I diabetes is this the trigger? Dow CT, Medical Hypotheses 2006 67 782 785 10.1016/j.mehy.2006.04.029 16828235
22. The TRIGR study. http://www.trigr.org
23. Mycobacterium avium subsp. Paratuberculosis in powdered infant milk. Pavlik I, Proceedings of the 8th international colloquium on paratuberculosis. Copenhagen, Denmark 2005 http://proc8.paratuberculosis.org/index.html
24. Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Naser SA Ghobrial G, Romero C Valentine JF, Lancet 2004 364 1039 1044 10.1016/S0140-6736(04)17058-X 15380962
25. Detection and Isolation of Mycobacterium avium subspecies paratuberculosis from intestinal mucosal biopsies of patients with and without Crohn's disease in Sardinia. Sechi LA Scanu AM, Molicotti P Cannas S, Mura M Dettori G, Fadda G Zanetti S, Am J Gastroenterol 2005 100 1529 1536 10.1111/j.1572-0241.2005.41415.x 15984976
26. Mycobacterium avium subspecies paratuberculosis bacteremia in type-1 diabetes mellitus: an infectious trigger? Sechi LA Paccagnini D, Salza S Pacifico A, Ahmed N Zanetti S, Clin Infect Dis 2008 46 148 149 10.1086/524084 18171233
27. The increasing incidence and prevalence of MS in a Sardinian province. Granieri E Casetta I, Govani V Tolam MR, Marchi D Murgia SB, Ticca A Pugliatti M, Murgia B Rosati G, Neurology 2000 55 842 848 10994006
28. Specific Immunoassays Confirm Association of Mycobacterium avium Subsp. paratuberculosis with Type-1 but Not Type-2 Diabetes Mellitus. Rosu V Ahmed N, Paccagnini D Gerlach G, Fadda G Hasnain SE, Zanetti S Sechi LA, PLoS ONE 2009 4 4386 10.1371/journal.pone.0004386 19204799
29. Genetic susceptibility to type1 diabetes. Maier LM Wicker LS, Current opinion in immunology 2005 17 601 608 10.1016/j.coi.2005.09.013 16226440
30. Functional genetic polymorphisms in cytokines and metabolic genes as additional genetic markers for susceptibility to develop type 1 diabetes. Eerligh P Koeleman BP, Dudbridge F Jan Bruining G, Roep BO Giphart MJ, Genes Immun 2004 5 36 40 10.1038/sj.gene.6364036 14735147
31. New autoimmune genes and the pathogenesis of type 1 diabetes. Hornum L Markholst H, Curr Diab Rep 2004 4 135 142 10.1007/s11892-004-0069-6 15035974
32. Association study of the NRAMP1 gene promote polymorphism and early-onset type 1 diabetes. Bassuny WM Ihara K, Matsuura N Ahmed S, Kohno H Kuromaru R, Miyako K Hara T, Immunogenetics 2002 54 282 285 10.1007/s00251-002-0459-3 12136340
33. Vitamin D receptor gene polymorphism affects onset pattern of type 1 diabetes. Motohashi Y Yamada S, Yanagawa T Maruyama T, Suzuki R Niino M, Fukazawa T Kasuga A, Hirose H Matsubara K, Shimada A Saruta T, J Clin Endocrinol Metab 2003 88 3137 3140 10.1210/jc.2002-021881 12843155
34. Understanding the multiple functions of Nramp1. Blackwell JM Searle S, Goswami T Miller EN, Microbes Infect 2000 2 317 321 10.1016/S1286-4579(00)00295- 1 10758409
35. SLC11a1, formerly Nramp1, is expressed in dendritic cells and influences Major Histocompatability complex ciass II expression and antigen presenting cell function. Stober CB Brode S White JK Jean-Francois P, Blackwell JM, Infection and Immunity 2007 75 5059 5067 10.1128/IAI.00153-07 17620357
36. Transcriptional control of Nramp1: a paradigm for the repressive action of c-Myc. Lapham AS Phillips ES Barton CH, Biochem Soc Trans 2004 32 1084 1086 10.1042/BST0321084 15506972
37. Host resistance to intracellular infection: mutation of natural resistance-associated macrophage protein 1 (Nramp1) impairs phagosomal acidification. Hackam DJ Rotstein OD, Zhang W Gruenheid S, Gros P Grinstein S, JExp Med 1998 188 351 364 10.1084/jem.188.2.351
38. Linking chronic infection and autoimmune diseases: Infection with Mycobacterium avium subspecies paratuberculosis, SLC11A1 polymorphism and Type-1 diabetes mellitus. Paccagnini D Sieswerda L, Rosu V Masala S, Pacifico A Gazouli M, Ikonomopoulos J Ahmed N, Zanetti S Sechi LA, PLoS ONE 2009 4 7109 10.1371/journal.pone.0007109 19768110
39. Structural basis of molecular mimicry. Wucherpfenniq KW, J Auto immune 2001 16 293 302
40. Molecular mimicry: can epitope mimicry induce autoimmune disease? Davies JM, Immunol Cell Biol 1997 75 113 126 10.1038/icb.1997.16 9107563
41. Role of heat shock proteins in protection from and pathogenesis of infectious diseases. Zugel U Kaufmann SH, Clin Microbiol Rev 1999 12 19 39 9880473
42. Autoantibodies in IDDM primarily recognize the 65,000-M (r) isoform of glutamic acid then the 67,000 (r) isoform of glutamic acid decarboxylase. Hagopian WA Michelson B, Karlsen AE Larsen F, Moody A Grubin CE, Rowe R Petersen J, McEvoy R Lernmark A, Diabetes 1993 42 631 636 10.2337/diabetes.42.4.631 8454115
43. Heat shock protein studies in type 1 and type 2 diabetes and human islet cell culture. Child DF Williams CP, Jones RP Hudson PR, Jones M Smith CJ, Diabetic Med 1995 12 595 599 10.1111/j.1464-5491.1995.tb00548.x 7554781
44. Immune modulation induced by tuberculosis DNA vaccine protects non- obese diabetic mice from diabetes progression. Santos R Sartori A Bonato VLD Coelho-Castelo AA, Vilella CA Zollner RL, Silva CL, Clin Exp Immunol 2007 148 570 578
45. Diabetes mellitus and infection. Larkin JG Frier BM Ireland JT, Postgrad Med J 1985 61 233 237 10.1136/pgmj.61.713.233 3885204
46. High seroprevalence of Helicobacter pylori in diabetes mellitus patients. Oldenburg B Diepersloot RJA Hoekstra JBL, Digest Dis Sci 1996 41 446 458 10.1007/BF02282318
47. The Role of H. pylori Infection in Diabetes. Ojetti V Migneco A, Silveri NG Ghirlanda G, Gasbarrini G Gasbarrini A, Curr Diabetes Rev 2005 1 343 347 10.2174/157339905774574275 18220610
48. Onset of Crohn's disease after Helicobacter pylori eradication. Tursi A, Inflamm Bowel Dis 2006 12 1008 1009 10.1097/01.mib.0000235100.09231.d7 17012975
49. Clinical onset of the Crohn's disease after eradication therapy of Helicobacter pylori infection: does Helicobacter pylori infection interact with natural history of inflammatory bowel diseases? Jovanovic IR Milosavjevic TN Jankovic GP Micev MM, Dugalic PD Saranovic D, Ugljesic MM Popovic DV, Bulajic MM, Med Sci Monit 2001 7 137 141 11208510
50. Molecular analysis of a leprosy immunotherapeutic bacillus provides insights into Mycobacterium evolution. Ahmed N Saini V Raghuvanshi S Khurana JP, Tyagi AK Tyagi A, Hasnain SE, PLoS ONE 2007 2 968 10.1371/journal.pone.0000968 17912347
51. Polyphasic taxonomic analysis establishes Mycobacterium indicus pranii as a distinct species. Saini V Raghuvanshi S, Talwar GP Ahmed N, Khurana JP Hasnain SE, Tyagi AK Tyagi AK, PLoS One 2009 4 6263 10.1371/journal.pone.0006263 19606228
52. The use of the name Mycobacterium w for the leprosy immunotherapeutic bacillus creates confusion with M. tuberculosis-W (Beijing strain): A suggestion. Talwar GP Ahmed N Saini V, Infect Genet Evol 2008 8 100 101 10.1016/j.meegid.2007.07.009 17766188
53. Mycobacterium avium subspecies paratuberculosis is not associated with type-2 diabetes mellitus. Rosu V Ahmed N, Paccagnini D Pacifico A, Zanetti S Sechi LA, Ann Clin Microbiol Antimicrobials 2008 7 9 10.1186/1476-0711-7-9
54. The "Perfect Storm" for Type 1 Diabetes. The complex interplay between intestinal microbiota, gut permeability and mucosal immunity. Vaarala O Atkinson MA, Neu J, Diabetes 2008 57 2555 2562 10.2337/db08-0331 18820210